Discovery of JANUVIA ™ (Sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Ann Weber

Seminar Series: Contemporary Biochemistry

Host:
Monday, October 30, 2006 – 3:30 PM